#Spain #Barcelona #Servier #AI Scalability #Veeva OpenData

Servier Embraces Veeva OpenData for Worldwide AI Integration

In a significant move within the pharmaceutical industry, Servier has announced its adoption of Veeva's OpenData on a global scale. The initiative aims to standardize customer reference data across more than 80 countries, thereby laying a robust foundation for Artificial Intelligence (AI) integration in its operational workflows. This undertaking was highlighted in a recent statement from the company, emphasizing a strategic shift towards harmonizing customer data to improve both efficiency and accuracy in targeting healthcare professionals.

A Unified Approach to Customer Data Management

Liam Hanrahan, the Global Operations Excellence Director at Servier, underscored the benefits of centralizing customer reference data through Veeva OpenData. He stated, "By standardizing our customer reference data, we are not only enhancing our current processes but also constructing a global database primed for AI, which will redefine how we operate."

The introduction of OpenData allows Servier to unify its fragmented data silos, creating a seamless flow of high-quality information that can facilitate better decision-making and operational agility. This new system, paired with VeevaLink, is set to empower Servier's global commercial and medical teams with interconnected data, enabling them to derive insights rapidly and respond dynamically to market demands.

Addressing Data Challenges in AI Initiatives

The pharmaceutical industry often grapples with scaling up AI initiatives; research indicates that a staggering 89% of AI endeavors face challenges primarily linked to data issues. Kilian Weiss, President of Link and OpenData at Veeva, pointed out that Servier is paving the way for a data-centric AI approach across all regions. He remarked, "Servier's leadership illustrates a proactive stance towards overcoming existing obstacles with a standardized AI data framework. By leveraging OpenData as a cornerstone for their harmonized global data platform, Servier can effectively enhance commercial execution driven by AI technology."

The integration of Veeva OpenData, which is part of the broader Veeva Data Cloud suite—comprising VeevaLink and VeevaCompass—will foster coherence and drive advanced analytics and AI scalability. This systematic approach not only replaces isolated data segments but also fortifies the foundation for comprehensive analysis and strategic growth.

Benefits for Global Operations

The adoption of Veeva OpenData signifies a fundamental shift in how Servier aims to operate on a global scale. With extensive improvements in data accuracy and accessibility, the organization anticipates streamlining processes and facilitating a more effective dialogue with healthcare professionals. The connection of relevant data will expedite making informed business decisions and enhance the overall effectiveness of Servier's global outreach programs.

This strategic initiative comes at a time when the life sciences sector is increasingly prioritizing technology as a means to drive innovation and operational excellence. Data-driven insights are becoming paramount for companies, enabling them to navigate complexities and seize new opportunities in an ever-evolving market.

Conclusion

As Servier embarks on this ambitious journey with Veeva OpenData, the implications for the pharmaceutical landscape could be profound. By laying a solid groundwork for AI integration, Servier not only enhances its operational capabilities but also stands to significantly improve patient outcomes through more tailored healthcare solutions. This undertaking signifies a leap forward in embracing technology in pharmaceuticals, showing the potential for data harmonization to lead to substantial advancements in care delivery.

For more information about Veeva and its solutions for the life sciences industry, visit Veeva.com/eu.